ALTO-100

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
ALTO-100 in Bipolar Disorder With Depression (BD-D)NCT06656416Alto NeurosciencePhase 2Recruiting2027-09Estimated
Phase 2b Study of ALTO-100 in MDDNCT05712187Alto NeurosciencePhase 2Completed2024-09-05Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.